OM:BIOG BBiotechs
BioGaia (OM:BIOG B): Reassessing Valuation After Strong Q3 Results and Operational Improvements
BioGaia (OM:BIOG B) just delivered a stronger third quarter, with sales and net income both climbing while the balance sheet stayed debt free. That combination, plus fresh product innovations, gives investors plenty to reassess.
See our latest analysis for BioGaia.
The share price tells a more cautious story, with a roughly flat 1 year total shareholder return of about minus 2 percent, even as the latest update hints at improving growth momentum and a healthier earnings profile.
If BioGaia's...